HRB National Drugs Library e-newsletter volume 18, issue 7

In this issue

International publications

Mapping prevention systems in the European Neighbourhood Policy area: a baseline for future monitoring and responses.

(2022) Lisbon: EMCDDA

Webinar: Preparing for the future — applying a foresight approach in the drugs field.

(2022) Lisbon: EMCDDA

EMCDDA trendspotter briefing. Responsiveness and preparedness in addressing drug-related needs of displaced Ukrainians in EU countries bordering Ukraine.

(2022) Lisbon: EMCDDA

Human rights in drug policy: a self-assessment tool.

Pompidou Group. (2022) Strasbourg: Council of Europe.

Swift, certain, tough: new consequences for drug possession.

(2022) London: Home Office.

Psychosocial and psychiatric factors preceding death by suicide: A case-control psychological autopsy study involving multiple data sources.

McMahon, Elaine M et al (2022) Suicide & Life-threatening Behavior, Early online.

Trauma-informed Wales: a societal approach to understanding, preventing and supporting the impacts of trauma and adversity.

ACE Hub Wales. (2022) Cardiff: Public Health Wales NHS Trust.

Adverse childhood experiences and adolescent drug use in the UK: the moderating role of socioeconomic position and ethnicity.

Karamanos, A et al (2022) SSM - Population Health, 19. doi: 10.1016/j.ssmph.2022

How the war on drugs impacts social determinants of health beyond the criminal legal system.

Cohen, Aliza et al (2022) Annals of Medicine, 54, (1), pp. 2024-2038.

Evidence paper: impact of investing in prevention on demand for statutory children’s social care.

Webb, Calum et al (2022) London: National Children's Bureau.

A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma.

Treloar, Carla et al (2022) Harm Reduction Journal, 19. doi: 10.1186/s12954-022-00658-w

Monitoring drug use in the digital age: studies in web surveys. The potential for using web surveys to investigate drug sales through cryptomarkets on the darknet.

Kardena, Alexandra and Strizek, Julian (2022) Lisbon: EMCDDA.

A report on British Columbia’s unregulated drug supply: drug checking trends across British Columbia January to December 2021.

Knill, Alison et al (2022) Vancouver: British Columbia Centre on Substance Use.

Community drug checking in music festivals: avenues for future research Shambhala 2019 report.

González-Nieto, Pablo et al (2022) British Columbia Centre on Substance Use.

Emotion regulation in substance use disorders: a systematic review and meta-analysis.

Stellern, Jordan et al (2022) Addiction, Early online. https://doi.org/10.1111/add.16001

Delivering alcohol, drugs and multiple risk training and workforce development across Glasgow city.

Scottish Drugs Forum Workforce Development Team (2022) Glasgow: Scottish Drugs Forum.

What is the volume, diversity and nature of recent, robust evidence for the use of peer support in health and social care? An evidence and gap map.

Price, Anna (2022) Campbell Systematic Reviews, 18, (3).

Polysubstance use in young people accessing residential and day treatment services for substance use: substance use profiles, psychiatric comorbidity, and treatment completion.

Mefodeva, Valeriya et al (2022) Addiction, Early online. doi: 10.1111/add.16008 (In Press)

Changing lives: our final report.

(2022) Edinburgh: Scottish Drug Deaths Taskforce.

The national drug-related deaths database (Scotland) report.

(2022) Edinburgh: Public Health Scotland.

The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment.

Glanz, Jason M et al (2022) Addiction, Early online. doi: 10.1111/add.15998 (In Press)

Estimating weekly national opioid overdose deaths in near real time using multiple proxy data sources.

Sumner, Steven A et al (2022) JAMA Network Open, 5, (7).

Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: a cohort study in New South Wales, Australia.

Brothers, Thomas D et al (2022) PLoS Medicine, 19, (7).

Geographic trends in opioid overdoses in the US from 1999 to 2020.

Post, Lori Ann et al (2022) JAMA Network Open, 5, (7), e2223631. https://doi.org/10.1001/jamanetworkopen.2022.23631

Priority setting for Canadian take-home naloxone best practice guideline development: an adapted online delphi method.

Ferguson, Max et al (2022) Harm Reduction Journal, 19. doi: 10.1186/s12954-022-00650-4

A rapid assessment of take-home naloxone provision during COVID-19 in Europe.

McDonald, Rebecca et al (2022) International Journal of Drug Policy, Early online. https://doi.org/10.1016/j.drugpo.2022.103787 (In Press)

Who is using take-home naloxone? An examination of supersavers.

Eide, Desiree et al (2022) Harm Reduction Journal, 19, (1), p. 65.

Feasibility of prospectively comparing opioid analgesia with opioid-free analgesia after outpatient general surgery: a pilot randomized clinical trial.

Do, Uyen et al (2022) JAMA Network Open, 5, (7).

A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement.

Sandhu, Reena K et al (2022) Harm Reduction Journal, 19. doi: 10.1186/s12954-022-00656-y

Development of a digital platform to improve community response to overdose and prevention among harm reduction organizations.

Claborn, Kasey et al (2022) Harm Reduction Journal, 19. doi: 10.1186/s12954-022-00636-2

The experience of safety, harassment and social exclusion among male clients of Sydney’s medically supervised injecting centre.

Dertadian, George and Tomsen, Stephen (2021) International Journal for Crime, Justice and Social Democracy, 10, (4).

Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis.

Yoon, Grace H et al (2022) Harm Reduction Journal, 19, (1), p. 73. doi: 10.1186/s12954-022-00655-z

Patients' experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study.

Marciuch, Anne et al (2022) Addiction Science & Clinical Practice, 17. doi: 10.1186/s13722-022-00317-2

Association of postsurgical opioid refills for patients with risk of opioid misuse and chronic opioid use among family members.

Agniel, Denis et al (2022) JAMA Network Open, 5, (7).

Prevalence of HIV preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use.

Streed, Carl G et al (2022) JAMA Network Open, 5, (7).

Can telemedicine optimize the HCV care cascade in people who use drugs? features of an innovative decentralization model and comparison with other micro-elimination strategies.

Nevola, Riccardo et al (2022) Biology, 11, (6). doi: 10.3390/biology11060805

Novel digital approaches to the assessment of problematic opioid use.

Freda, Philip J et al (2022) BioData Mining, 15. doi: 10.1186/s13040-022-00301-1

Acute pancreatitis as a rare adverse event among cannabis users: A systematic review.

Jaiswal, Vikash et al (2022) Medicine, 101, (26), e29822.

A critical review of cannabis in medicine and dentistry: a look back and the path forward.

Abidi, Ammaar H et al (2022) Clinical and Experimental Dental Research, 8, (3), pp. 613-631.

Adjunctive transdermal cannabidiol for adults with focal epilepsy: a randomized clinical trial.

O'Brien, Terence J et al (2022) JAMA Network Open, 5, (7).

Use of electronic cigarettes among cannabis-naive adolescents and its association with future cannabis use.

Sun, Ruoyan et al (2022) JAMA Network Open, 5, (7).

The declining trend in adolescent drinking: do volume and drinking pattern go hand in hand?

Rossow, Ingeborg et al (2022) International Journal of Environmental Research and Public Health, 19, (13).

Prices, taxes and alcohol use: a systematic umbrella review.

Guindon, G Emmanuel et al (2022) Addiction, Early online. https://doi.org/10.1111/add.15966

Differential impact of minimum unit pricing on alcohol consumption between Scottish men and women: controlled interrupted time series analysis.

Rehm, Jürgen et al (2022) BMJ Open, 12. doi: 10.1136/bmjopen-2021-054161

Alcohol packaging as a promotional tool: a focus group study with young adult drinkers in Scotland.

Jones, Daniel et al (2022) Journal of Studies on Alcohol and Drugs, 83, (4), pp. 565-573

Structural differences in adolescent brainscan predict alcohol misuse.

Rane, Roshan Prakash et al (2022) eLife, 11. https://doi.org/10.7554/elife.77545

Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.

GBD 2020 Alcohol Collaborators. (2022) The Lancet, 400, (10347), pp. 185-235.

Practitioner and digitally delivered interventions for reducing hazardous and harmful alcohol consumption in people not seeking alcohol treatment: a systematic review and network meta-analysis.

Beyer, Fiona R et al (2022) Addiction, Early online. doi: 10.1111/add.15999

Employment status and alcohol-attributable mortality risk-a systematic review and meta-analysis.

Saul, Celine et al (2022) International Journal of Environmental Research and Public Health, 19, (12). doi: 10.3390/ijerph19127354

Solitary alcohol use in adolescence predicts alcohol problems in adulthood: a 17-year longitudinal study in a large national sample of US high school students.

Creswell, Kasey G et al (2022) Drug and Alcohol Dependence, Early online. https://doi.org/10.1016/j.drugalcdep.2022.109552 (In Press)

How do we deal with a problem like the alcohol industry? Four lessons on how to protect science based on recent study.

Mitchell, G and McCambridge, Jim (2022) JSAD FastTakes, doi:10.15288/jsad-FT.07.11.2022-6

Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: observational and mendelian randomization analyses.

Topiwala, Anya et al (2022) PLoS Medicine, 19, (7).

Alcohol consumption at age 18-25 and number of children at a 33-year follow-up: Individual and within-pair analyses of Finnish twins.

Rose, Richard J et al (2022) Alcoholism, Clinical and Experimental Research, Early online. doi: 10.1111/acer.14886

Alcohol misuse in patients with alcohol-related liver disease: How can we do better? A narrative review of the literature.

Horrell, Jane et al (2022) Alcoholism, Clinical and Experimental Research, Early online. doi: 10.1111/acer.14895

Targeting unmet clinical needs in the treatment of alcohol use disorder.

Lohoff, Falk W (2022) Frontiers in Psychiatry, 13. doi: 10.3389/fpsyt.2022.767506

Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double-blind, multi-site randomized controlled trial.

Manning, Victoria et al (2022) Addiction, Early online. doi: 10.1111/add.15989

Definition matters: assessment of tolerance to the effects of alcohol in a prospective cohort study of emerging adults.

O'Dean, Siobhan M et al (2022) Addiction, Early online. doi: 10.1111/add.15991

Behavioral economics indices predict alcohol use and consequences in young men at 4-year follow-up.

Gaume, Jacques et al (2022) Addiction, Early online. doi: 10.1111/add.15986

Women, alcohol, pregnancy and FASD.

Plant, Moira (2022) QNIS Blog.

Risk pathways contributing to the alcohol harm paradox: socioeconomic deprivation confers susceptibility to alcohol dependence greater exposure to aversive experience, internalizing symptoms and drinking to cope.

Shuai, Ruichong (2022) Frontiers in Behavioral Neuroscience, 16.

The COVID hangover: addressing long-term health impacts of changes in alcohol consumption during the pandemic.

Boniface, Sadie et al (2022) London: Institute of Alcohol Studies.

Brazil in the regional and transatlantic cocaine supply chain: the impact of COVID-19.

Cocaine insights 4. UNODC, CoE Brazil. (2022) Vienna: UNODC.

Li, Yuansen et al (2022) Frontiers in Medicine, 9. doi: 10.3389/fmed.2022.783121

Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm.

Bates, Geoff et al (2022) International Journal of Drug Policy, 107.

ACMD report – A review of the evidence on the use and harms of 2-benzyl benzimidazole (‘nitazene’) and piperidine benzimidazolone (‘brorphine-like’) opioids.

(2022) London: Advisory Council on the Misuse of Drugs.

Infographic: synthetic cathinones notifications to the Early Warning System and seizures.

(2022) EMCDDA

CCENDU drug alert: Xylazine.

(2022) Ottawa: Canadian Centre on Substance Use and Addiction.

N-Propyl Butylone.

Krotulski, Alex J et al (2022) Pennsylvania: Center for Forensic Science Research & Education

Ketamine assisted psychotherapy: a systematic narrative review of the literature.

Drozdz, Sandra J et al (2022) Journal of Pain Research, 15. pp. 1691-1706.

Vaping cannabinoid acetates leads to ketene formation.

Munger, Kaelas R et al (2022) Chemical research in toxicology, (Working paper). 10.26434/chemrxiv-2022-v379b-v2

Copyright © 2022 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on alcohol and other drugs research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries. Not sure what we can do for you? Email us and we will be happy to discuss your information needs.